Creat membership Creat membership
Sign in

Forgot password?

Confirm
  • Forgot password?
    Sign Up
  • Confirm
    Sign In
Creat membership Creat membership
Sign in

Forgot password?

Confirm
  • Forgot password?
    Sign Up
  • Confirm
    Sign In
Collection

toTop

If you have any feedback, Please follow the official account to submit feedback.

Turn on your phone and scan

home > search >

A new biomarker - index of Cardiac Electrophysiological Balance (iCEB) - plays an important role in drug-induced cardiac arrhythmias: beyond QT-prolongation and Torsades de Pointes (TdPs)

Author:
Lu, Hua Rong  Yan, Gan-Xin  Gallacher, David J.  


Journal:
JOURNAL OF PHARMACOLOGICAL AND TOXICOLOGICAL METHODS


Issue Date:
2013


Abstract(summary):

Introduction: In the present study, we investigated whether a new biomarker - index of cardiac electrophysiological balance (iCEB = QT/QRS) - could predict drug-induced cardiac arrhythmias (CAs), including ventricular tachycardia/ventricular fibrillation (VT/VF) and Torsades de Pointes (TdPs). Methods: The rabbit left ventricular arterially-perfused-wedge was used to investigate whether the simple iCEB measured from the ECG is reflective of the more difficult measurement of lambda (effective refractory periodxconduction velocity) for predicting CAs induced by a number of drugs. Results: Dofetilide concentration-dependently increased iCEB and lambda, predicting potential risk of drug-induced incidence of early afterdepolarizations (EADs) starting at 0.01 mu M. Digoxin (1 and 5 mu M), encainide (5 and 20 mu M) and propoxyphene (10 and 100 mu M) markedly reduced both iCEB and lambda, predicting their ability to induce non-TdP-like VT/VF. At 10 mu M, both NS1643 and levcromakalim significantly decreased lambda and iCEB, which was preceded with presence of non-TdP-like VT/VF. Isoprenaline (0.05 to 0.5 mu M) significantly reduced both lambda and iCEB, which was associated with a high incidence of non-TdP-like VT/VF in most preparations. Other biomarkers (i.e. transmural dispersion of T-wave and instability of the QT interval) predicted only dofetilide-induced long QT and EADs, but did not predict drug-induced risk of non-TdP-like VT/VF. Discussion: Our data from 7 reference drugs of known pro-arrhythmic effects suggests that 1) this non-invasive iCEB predicts potential risk of drug-induced CAs beyond long QT and TdP; 2) iCEB is more useful than the current biomarkers (i.e. transmural dispersion and instability) in predicting potential risks for drug-induced non-TdP-like VT/VF. (C) 2013 Elsevier Inc. All rights reserved.


Page:
250---259


Similar Literature

Submit Feedback

This function is a member function, members do not limit the number of downloads